[
  {
    "ticker": "VBX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968862",
    "id": "02968862",
    "pages": 12,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq8jmjzrv76.pdf",
    "summary": "<p>Here\u2019s the concise extraction of material information from the ASX announcement:  </p>\n<h3><strong>Key Points (Quarterly Activities Report + Capital Markets Summary)</strong></h3>\n<ul>\n<li><strong>IPO</strong>: Successfully completed, raising <strong>$10 million</strong> (16.7m shares at $0.60). Oversubscribed by institutional/sophisticated investors.  </li>\n<li><strong>Project Highlights (Wuudagu Bauxite)</strong>:  </li>\n<li><strong>PFS Results</strong>: Pre-tax NPV8 <strong>$821m</strong>, IRR <strong>136%</strong>, avg. EBITDA <strong>$143m/year</strong>, payback <strong>16 months</strong>.  </li>\n<li><strong>Reserve</strong>: 59Mt Probable Reserve over 10-year mine life (3.5Mtpa production).  </li>\n<li><strong>Cost Advantage</strong>: First-quartile cost curve (AISC <strong>$54/t</strong> CFR China).  </li>\n<li><strong>Product Quality</strong>: High-grade, low-silica bauxite (45.4% Al2O3, 3.6% SiO2), attracting premium pricing (~US$75/t).  </li>\n<li><strong>Market Context</strong>:  </li>\n<li>Chinese bauxite demand at record highs (+25% CAGR since 2005); supply risks in Guinea (50% export capacity licence withdrawals).  </li>\n<li>Wuudalu positioned to benefit from supply gap, with pricing similar to Guinean product.  </li>\n<li><strong>Near-Term Catalysts</strong>:  </li>\n<li><strong>Drilling</strong>: Ongoing exploration/infill (targeting resource upgrade for DFS).  </li>\n<li><strong>DFS Completion</strong>: Targeted Q4 2025; production start Q4 2026.  </li>\n<li><strong>Financials (30 June 2025)</strong>:  </li>\n<li><strong>Cash Balance</strong>: <strong>$9.5m</strong> (no debt).  </li>\n<li><strong>Use of Funds</strong>: Majority of IPO proceeds ($9.5m) remain for project development.  </li>\n</ul>\n<h3><strong>Omitted</strong>: Director commentary, tenement details, compliance statements, and non-material operational updates.</h3>\n<p><strong>Conciseness Note</strong>: Focused purely on data impacting valuation, liquidity, or capital structure. Market context included due to material pricing/supply dynamics.</p>",
    "usage": {
      "prompt_tokens": 7363,
      "completion_tokens": 432,
      "total_tokens": 7795,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:38.457277"
  },
  {
    "ticker": "OCC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968863",
    "id": "02968863",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0829",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrqbmy0j58fr.pdf",
    "summary": "<ul>\n<li><strong>Cessation of Securities</strong>:  </li>\n<li><strong>Security</strong>: OCCAV (Options expiring 13-Jul-2025, exercise price $0.403)  </li>\n<li>\n<p><strong>Quantity Cessation</strong>: 250,000 options expired unexercised (13/07/2025).  </p>\n</li>\n<li>\n<p><strong>Post-Cessation Capital Structure</strong>:  </p>\n</li>\n<li><strong>Ordinary Shares (OCC)</strong>: 244,800,004 fully paid.  </li>\n<li><strong>Outstanding Unquoted Options/Rights</strong>:  <ul>\n<li>Multiple tranches with varying expiries (2025\u20132029) and exercise prices ($0.36\u2013$0.90).  </li>\n<li>Notable: 3M OCCAAK ($0.67 expiry Oct-2027), 3M OCCAW ($0.40 expiry Mar-2028), 1.87M Performance Rights (OCCAY).  </li>\n</ul>\n</li>\n</ul>\n<p><strong>No material trading or capital structure impact</strong> (routine expiry of out-of-the-money options).</p>",
    "usage": {
      "prompt_tokens": 1499,
      "completion_tokens": 208,
      "total_tokens": 1707,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:25.658130"
  },
  {
    "ticker": "VG1",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968861",
    "id": "02968861",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0828",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq64p0xxn8d.pdf",
    "summary": "<p><strong>Weekly NTA Update</strong><br />\n- <strong>NTA per share (11 July 2025):</strong> $2.06 (post-tax, post-fees, unaudited).  </p>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 622,
      "completion_tokens": 46,
      "total_tokens": 668,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:15.980568"
  },
  {
    "ticker": "RMS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968858",
    "id": "02968858",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpzrkyls2pl.pdf",
    "summary": "<ul>\n<li><strong>Scheme Approval</strong>: Spartan shareholders approved the proposed acquisition by Ramelius Resources, with 90.3% of eligible shareholders voting in favor and 96.3% of votes cast supporting the resolution.  </li>\n<li><strong>Transaction Terms</strong>: $0.25 cash + 0.6957 new Ramelius shares per Spartan share.  </li>\n<li><strong>Key Dates</strong>:  </li>\n<li>Court hearing for Scheme approval: <strong>21 July 2025</strong>.  </li>\n<li>Last trading day for Spartan shares: <strong>22 July 2025</strong> (if approved).  </li>\n<li>Scheme record date: <strong>24 July 2025</strong>.  </li>\n<li>Implementation date: <strong>31 July 2025</strong>.  </li>\n<li><strong>Next Steps</strong>: Scheme effectiveness contingent on court approval and ASIC lodgement (expected <strong>22 July 2025</strong>).</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1796,
      "completion_tokens": 164,
      "total_tokens": 1960,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:09.042930"
  },
  {
    "ticker": "AXE",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968859",
    "id": "02968859",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq1tt9h7cqw.pdf",
    "summary": "<h3><strong>Archer Materials \u2013 Quarterly Report (Appendix 4C) \u2013 Key Takeaways</strong></h3>\n<ul>\n<li><strong>Cash Position</strong>: Closing cash balance of <strong>$13.7M</strong> (no debt).  </li>\n<li><strong>R&amp;D Progress</strong>:  </li>\n<li><strong>Quantum Computing (12CQ)</strong>: Extended collaboration with Queen Mary University London to advance qubit development (targeting 1HCY26 demonstration).  </li>\n<li><strong>Biochip</strong>:  <ul>\n<li>Signed agreement with <strong>Paragraf</strong> to improve graphene-based biosensor (gFET) for blood potassium testing.  </li>\n<li>Fabricated integrated silicon chip (gFET + readout circuitry) for handheld blood-testing device.  </li>\n</ul>\n</li>\n<li><strong>Strategic Move</strong>: Formed <strong>advisory committee</strong> (chaired by semiconductor/medtech experts) to guide commercialization.  </li>\n<li><strong>Investments</strong>: Holdings in <strong>Volatus Capital (CSE:VC)</strong> and <strong>ChemX Materials (ASX:CMX)</strong>.  </li>\n<li><strong>Burn Rate</strong>: Net operating cash outflow of <strong>$1.78M</strong> (7.7 quarters of runway at current rate).  </li>\n</ul>\n<p><strong>No material capital-raising or trading halt information identified.</strong></p>",
    "usage": {
      "prompt_tokens": 5162,
      "completion_tokens": 236,
      "total_tokens": 5398,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:57.023898"
  },
  {
    "ticker": "FPR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968860",
    "id": "02968860",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrq3xkz0nznr.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Shares Bought Back (Previous Day)</strong>: 92,000  </li>\n<li><strong>Cumulative Shares Bought Back</strong>: 79,465,974  </li>\n<li><strong>Daily Buy-back Consideration (Previous Day)</strong>: AUD 294,050.40 (avg. ~AUD 3.20/share)  </li>\n<li><strong>Price Range (Previous Day)</strong>: AUD 3.16 (low) to AUD 3.22 (high)  </li>\n<li><strong>Buy-back Period</strong>: 10/5/2023 to 23/1/2026  </li>\n<li><strong>Maximum Approved Buy-back</strong>: 25 million shares (post-AGM approval on 23/1/2025)  </li>\n<li><strong>Broker</strong>: Morgan Stanley Australia Securities Limited</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1547,
      "completion_tokens": 164,
      "total_tokens": 1711,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:05.997531"
  },
  {
    "ticker": "ATG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968857",
    "id": "02968857",
    "pages": 26,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0826",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpxk2hh08cj.pdf",
    "summary": "<h3>Summary of ASX Announcement: Extraordinary General Meeting (EGM) Notice \u2013 Articore Group Limited</h3>\n<h4><strong>Key Material Information</strong>:</h4>\n<ol>\n<li><strong>EGM Called by Shareholders</strong>  </li>\n<li>\n<p>Requested by shareholders holding <strong>\u22655% of issued capital</strong>, seeking to replace the entire Board with four new directors (including former Chair Richard Cawsey).  </p>\n</li>\n<li>\n<p><strong>Board Recommendation</strong>  </p>\n</li>\n<li><strong>Unanimously opposes all resolutions</strong> to remove current directors (Mendelson, Low, Sherwin, Lewis) and elect new candidates.  </li>\n<li>\n<p>Argues the requisitioning shareholders lack a strategic plan, and a geographically concentrated (Australia-only) Board risks undermining global operations (90% revenue offshore).  </p>\n</li>\n<li>\n<p><strong>Turnaround Progress</strong>  </p>\n</li>\n<li>New CEO Vivek Kumar has improved <strong>1HFY25 gross profit margin (+220bps YoY)</strong> and reaffirmed FY25 guidance.  </li>\n<li>\n<p>Strategic review underway for <strong>capital structure, portfolio positioning, and cost efficiencies</strong>.  </p>\n</li>\n<li>\n<p><strong>EGM Details</strong>  </p>\n</li>\n<li><strong>Date</strong>: 22 August 2025 (10:00 AEST).  </li>\n<li><strong>Voting Deadline</strong>: 20 August 2025 (10:00 AEST).  </li>\n</ol>\n<h4><strong>Impact</strong>:</h4>\n<ul>\n<li>High-stakes governance battle; outcome could shift strategy and leadership continuity amid a turnaround.  </li>\n</ul>\n<p><strong>Omitted</strong>: Director bios, legal boilerplate, requisitioning shareholders' statements (no materially new strategy proposed).</p>",
    "usage": {
      "prompt_tokens": 12467,
      "completion_tokens": 303,
      "total_tokens": 12770,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:51.650178"
  },
  {
    "ticker": "NDO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968854",
    "id": "02968854",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpq5gf21m2q.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Securities Bought Back (as of 11/7/2025)</strong>: 710,179 (680,329 before previous day + 29,850 on previous day)  </li>\n<li><strong>Remaining Buy-back Capacity</strong>: 21,856,557 shares (out of maximum 22,566,736)  </li>\n<li><strong>Price Range</strong>: AUD 0.65 (low) to AUD 0.82 (high)  </li>\n<li><strong>Current Buy-back Period</strong>: 14/3/2025 to 13/3/2026  </li>\n<li><strong>Broker</strong>: MA Moelis Australia Securities Pty Ltd  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1499,
      "completion_tokens": 145,
      "total_tokens": 1644,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:29.469959"
  },
  {
    "ticker": "OSX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968852",
    "id": "02968852",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpl0gdz4qpr.pdf",
    "summary": "<ul>\n<li><strong>Regulatory Approval</strong>: Osteopore secures Swiss market approval under EU Medical Device Regulation (MDR), completing its product portfolio for Switzerland and Europe.  </li>\n<li><strong>Partnership</strong>: Strengthens distribution via exclusive agreement with Zimmer Biomet for EMEA, APAC, Australia, and New Zealand.  </li>\n<li><strong>Market Opportunity</strong>: European cranial implant market projected to reach ~USD 527.6M by 2027, with custom implants as the largest segment.  </li>\n</ul>\n<p><em>No material trading or capital markets impacts identified (e.g., no raise, no financial data).</em></p>",
    "usage": {
      "prompt_tokens": 1567,
      "completion_tokens": 117,
      "total_tokens": 1684,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:42.694531"
  },
  {
    "ticker": "DNL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968853",
    "id": "02968853",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpn2p6b53pq.pdf",
    "summary": "<ul>\n<li><strong>Buy-back type</strong>: On-market  </li>\n<li><strong>Total shares bought back</strong> (cumulative): 111,848,671 (+ <strong>578,704</strong> on previous day)  </li>\n<li><strong>Buy-back program</strong>: Up to <strong>AUD $400 million</strong> (no fixed share target)  </li>\n<li><strong>Current spend</strong>: AUD <strong>326.3M</strong> (cumulative) + AUD <strong>1.64M</strong> (previous day)  </li>\n<li><strong>Price range (previous day)</strong>: AUD <strong>2.82\u20132.86</strong> (highest allowed: AUD <strong>2.92</strong>)  </li>\n<li><strong>Program dates</strong>: <strong>13/5/2025</strong> to <strong>28/11/2025</strong>  </li>\n<li><strong>Broker</strong>: UBS Securities Australia  </li>\n</ul>\n<p><em>No material changes to capital structure or new trading signals identified.</em></p>",
    "usage": {
      "prompt_tokens": 1579,
      "completion_tokens": 166,
      "total_tokens": 1745,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:48.413839"
  },
  {
    "ticker": "VG1",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968856",
    "id": "02968856",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpvd2rbd2vw.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total shares bought back as of previous day</strong>: 14,608,249  </li>\n<li><strong>Shares bought back on 11/7/2025</strong>: 9,626  </li>\n<li><strong>Maximum buy-back target</strong>: 67,382,076 (remaining: 52,764,201 as of 11/7/2025)  </li>\n<li><strong>Buy-back period</strong>: 26/11/2024 to 24/11/2025 (estimated dates)  </li>\n<li><strong>Daily buy-back details (11/7/2025)</strong>:  </li>\n<li><strong>Total consideration</strong>: AUD 16,958.67  </li>\n<li><strong>Price range</strong>: AUD 1.755\u20131.765 (lowest\u2013highest)  </li>\n<li><strong>Highest allowable price per ASX rule</strong>: AUD 1.8416  </li>\n<li><strong>Broker</strong>: Third Party Platform Pty Ltd  </li>\n</ul>\n<p>No material valuation or liquidity impacts beyond ongoing buy-back execution.</p>",
    "usage": {
      "prompt_tokens": 1568,
      "completion_tokens": 202,
      "total_tokens": 1770,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:31.922586"
  },
  {
    "ticker": "CWY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968851",
    "id": "02968851",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrphxnwh3r7t.pdf",
    "summary": "<p><strong>Form 604 \u2013 Change in Substantial Holding (Cleanaway Waste Management Ltd.)</strong>  </p>\n<ul>\n<li><strong>Substantial Holder:</strong> The Capital Group Companies, Inc. (via Capital Research and Management Company).  </li>\n<li><strong>Change in Holding:</strong> Increased stake from <strong>5.25% (117,217,544 shares)</strong> to <strong>6.31% (140,839,294 shares)</strong>.  </li>\n<li><strong>Key Transactions (Annexure A):</strong>  </li>\n<li>Largest single acquisition: <strong>7,000,000 shares</strong> (AUD 19.25M) on <strong>19-Jun-2025</strong>.  </li>\n<li>Recent purchases (10-Jul-2025): <strong>1,393,088 shares</strong> (AUD 3.94M).  </li>\n<li>Total estimated consideration (all transactions): <strong>~AUD 56.76M</strong> (calculated from listed amounts).  </li>\n</ul>\n<p><strong>Material Implication:</strong> Significant institutional accumulation (+1.06% stake), signaling bullish outlook. Monitor for further buying activity.</p>",
    "usage": {
      "prompt_tokens": 2034,
      "completion_tokens": 206,
      "total_tokens": 2240,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:36:14.112989"
  },
  {
    "ticker": "BMM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968847",
    "id": "02968847",
    "pages": 7,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp7k1dzs234.pdf",
    "summary": "<h3>Material Information Summary:</h3>\n<ul>\n<li><strong>New Strategic Claims Staked</strong>: Bayan has applied for 45 new lode claims (\"Desert Star North Project\"), expanding its landholding to <strong>117 claims</strong> (~3.75 km\u00b2) in a rare earth/gold corridor.  </li>\n<li><strong>Proximity to Major Deposits</strong>: Claims are <strong>3 km north</strong> of Colosseum Gold Mine (JORC Resource: <strong>27.1 Mt @ 1.26 g/t Au</strong>) and near Mountain Pass Rare Earth Mine.  </li>\n<li><strong>Exploration Plan</strong>: Reconnaissance mapping and geochemical sampling to commence <strong>in coming weeks</strong>; targeting REE/gold mineralization.  </li>\n<li><strong>Key Risk</strong>: BLM claim grants pending\u2014final tenure status to be confirmed.  </li>\n</ul>\n<p><em>No capital raising, financials, or trading halt details identified.</em></p>",
    "usage": {
      "prompt_tokens": 3151,
      "completion_tokens": 172,
      "total_tokens": 3323,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:57.023635"
  },
  {
    "ticker": "I88",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968849",
    "id": "02968849",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpcr40jrzlm.pdf",
    "summary": "<h3>Summary of ASX Announcement \u2013 Infini Resources (ASX: I88)</h3>\n<p><strong>Announcement Type: Exploration Update</strong>  </p>\n<ul>\n<li><strong>Project:</strong> Portland Creek Uranium Project (100%-owned).  </li>\n<li><strong>Key Findings:</strong>  </li>\n<li><strong>Uranium-in-soil anomalies</strong> up to <strong>74,997 ppm U\u2083O\u2088 (~7.5%)</strong> over a <strong>6km corridor</strong>, with primary structures untested in Phase 1 drilling.  </li>\n<li><strong>New structural/uranium experts engaged</strong> (Newexco, Mark Couzens) to refine exploration model for <strong>Phase 2 drilling</strong> (Q3 2025).  </li>\n<li>\n<p><strong>Potential for large-scale uranium deposit</strong> inferred from high-grade soils, hydrothermal alteration, and pathfinder elements.  </p>\n</li>\n<li>\n<p><strong>Next Steps:</strong>  </p>\n</li>\n<li>Phase 2 diamond drilling planned for <strong>Q3 2025</strong>, targeting shear-hosted or alternative uranium styles.  </li>\n</ul>\n<p><strong>No capital, financial, or trading halt information disclosed.</strong>  </p>\n<p><em>Brevity note: Excluded operational/background details (e.g., historic resources, project location) as they do not materially impact near-term valuation or liquidity.</em></p>",
    "usage": {
      "prompt_tokens": 3254,
      "completion_tokens": 243,
      "total_tokens": 3497,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:46.657054"
  },
  {
    "ticker": "GUM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968846",
    "id": "02968846",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp5gstrb8hd.pdf",
    "summary": "<h3>Summary (Appendix 3Y - Change of Director\u2019s Interest Notice):</h3>\n<ul>\n<li><strong>Director</strong>: Geoff Stalley  </li>\n<li><strong>Change Type</strong>: Indirect on-market purchase of shares via Finclear Services Pty Ltd (Superhero Securities A/C).  </li>\n<li><strong>Securities</strong>: 5,500 fully paid ordinary shares acquired at <strong>$0.095 per share</strong>.  </li>\n<li><strong>Holding Post-Change</strong>: 55,500 shares (previously 50,000).  </li>\n<li><strong>Additional Note</strong>: Late filing due to administrative oversight; deemed isolated.  </li>\n</ul>\n<p>No material impact on valuation, liquidity, or capital structure identified.</p>",
    "usage": {
      "prompt_tokens": 1173,
      "completion_tokens": 128,
      "total_tokens": 1301,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:44.688883"
  },
  {
    "ticker": "VTM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968848",
    "id": "02968848",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp9msys51bh.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<ul>\n<li><strong>U.S. Federal Approval Secured</strong>: Victory Metals (ASX: VTM) receives SAM.gov approval, allowing direct engagement with the U.S. Department of Defense (DoD) and access to federal programs (e.g., Defense Production Act, EXIM Bank funding).  </li>\n<li><strong>Key Implications</strong>:  </li>\n<li>Eligibility for strategic procurement, federal funding (including previously announced US$190M LOI from EXIM Bank).  </li>\n<li>Strengthened credibility for global offtake agreements, particularly with U.S., Japanese, and European partners.  </li>\n<li>Validation as a secure, non-Chinese critical minerals supplier (heavy rare earths, Scandium, Hafnium, Gallium).  </li>\n<li><strong>Project Highlight</strong>: North Stanmore (WA) is a major heavy rare earths deposit with low radioactivity and high-value elements (Dysprosium, Terbium).  </li>\n</ul>\n<p><em>No financial/trading actions or capital structure impacts identified.</em>  </p>\n<p><em>(Omitted: CEO quote, operational details, non-material project specifics.)</em></p>",
    "usage": {
      "prompt_tokens": 1161,
      "completion_tokens": 219,
      "total_tokens": 1380,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:38.596776"
  },
  {
    "ticker": "ETM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968850",
    "id": "02968850",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpftwrbnhny.pdf",
    "summary": "<h3>Summary of ASX Announcement:</h3>\n<ul>\n<li><strong>Potential Acquisition</strong>: ETM's subsidiary (ETM Spain) submitted a <strong>binding offer of \u20ac3.6M (~A$6.4M)</strong> to acquire the Penouta Mine (Spain), a tin-tantalum-niobium asset.  </li>\n<li><strong>Key Conditions</strong>: Offer subject to being selected as preferred bidder, regulatory approvals, and execution of sale deed. <strong>\u20ac500K deposit paid</strong> (refundable if unsuccessful).  </li>\n<li><strong>Strategic Rationale</strong>: Penouta is Europe\u2019s sole tantalum-niobium mine, aligning with ETM\u2019s diversification strategy.  </li>\n<li><strong>Uncertainty</strong>: No assurance of successful bid; competing offers may still emerge. Expected completion by <strong>end-2025</strong> if approved.  </li>\n<li><strong>Funding</strong>: To be funded from existing cash reserves.  </li>\n</ul>\n<p><strong>Material Impact</strong>: Potential expansion into critical minerals, but high execution risk due to competitive bid process and approvals.  </p>\n<p><em>Omitted: Background on other projects, director contacts, legal boilerplate.</em></p>",
    "usage": {
      "prompt_tokens": 1291,
      "completion_tokens": 217,
      "total_tokens": 1508,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:48.296191"
  },
  {
    "ticker": "POL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968842",
    "id": "02968842",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnx4s05ky9p.pdf",
    "summary": "<ul>\n<li><strong>Capital Raising Announcement</strong>: Placement of 18,750,000 shares to exempt investors under Section 708A of Corporations Act.  </li>\n<li><strong>No other material information identified</strong> (cleansing notice only confirms regulatory compliance).  </li>\n</ul>\n<p><em>Note: No details on capital raised (AUD), pricing, or use of proceeds provided in this notice.</em></p>",
    "usage": {
      "prompt_tokens": 550,
      "completion_tokens": 72,
      "total_tokens": 622,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:18.756184"
  },
  {
    "ticker": "JLL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968845",
    "id": "02968845",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp3d195drz2.pdf",
    "summary": "<p><strong>Summary of ASX Announcement</strong>  </p>\n<ul>\n<li><strong>Appointment of Key Executive</strong>: Matt Haas appointed as Vice President \u2013 Studies and Development to lead US operations for the McDermitt Lithium Project.  </li>\n<li><strong>Project Advancement</strong>: Role focused on advancing technical studies (mining, processing, infrastructure) for McDermitt, a major US lithium asset.  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified</em> (Executive appointment only, no financial/capital structure changes disclosed).</p>",
    "usage": {
      "prompt_tokens": 1439,
      "completion_tokens": 95,
      "total_tokens": 1534,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:32:49.608193"
  },
  {
    "ticker": "LSF",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968844",
    "id": "02968844",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrp1bb0p2v2v.pdf",
    "summary": "<ul>\n<li><strong>NTA per Share (pre-tax) as of 09 July 2025</strong>: $3.3330  </li>\n<li><strong>NTA per Share (post-tax) as of 09 July 2025</strong>: $3.1782  </li>\n</ul>\n<p>(Note: No material trading or capital markets decisions identified beyond NTA update.)</p>",
    "usage": {
      "prompt_tokens": 440,
      "completion_tokens": 67,
      "total_tokens": 507,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:12.857635"
  },
  {
    "ticker": "AOK",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968843",
    "id": "02968843",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnz70d62pw9.pdf",
    "summary": "<p><strong>Operational Business Update Summary:</strong>  </p>\n<ul>\n<li><strong>Reclamation Board Wells (Rec Board-7 &amp; -8):</strong>  </li>\n<li>Currently flowing unassisted at <strong>215 mscf/d</strong> (peak 275 mscf/d).  </li>\n<li>\n<p>Plan to install smaller compressors to boost flows further.  </p>\n</li>\n<li>\n<p><strong>Borba Well (Californian leases):</strong>  </p>\n</li>\n<li><strong>Uneconomic</strong> due to small gas pool (0.5\u20131.5 Bcf), high nitrogen content, and lack of pipeline access.  </li>\n<li>\n<p>Leases expired; asset deemed immaterial.  </p>\n</li>\n<li>\n<p><strong>Dempsey Well:</strong>  </p>\n</li>\n<li>Shut in due to integrity issues; reviewing remediation potential.  </li>\n<li>\n<p>Lease not material; may be relinquished.  </p>\n</li>\n<li>\n<p><strong>Other Leases:</strong>  </p>\n</li>\n<li><strong>Malton, Los Medanos, Dutch Slough:</strong> Shut-in royalties paid; assessing tie-in/redevelopment.  </li>\n<li>\n<p><strong>Rio Vista:</strong> Producing (Rec Board-7 &amp; -8; 100% WI).  </p>\n</li>\n<li>\n<p><strong>New Ventures:</strong>  </p>\n</li>\n<li>Evaluating opportunities in Africa, South America, and Australasia amid energy security trends.  </li>\n<li>Strengthened balance sheet post-recent settlement (3 July 2025).  </li>\n</ul>\n<p><strong>No material financial data (e.g., cash balance) or capital markets activity disclosed.</strong></p>",
    "usage": {
      "prompt_tokens": 3124,
      "completion_tokens": 277,
      "total_tokens": 3401,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:41.567138"
  },
  {
    "ticker": "MAQ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968840",
    "id": "02968840",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrns09fcgryz.pdf",
    "summary": "<h3>Summary of Material Information:</h3>\n<ul>\n<li><strong>Land Acquisition for Data Centre Campus</strong> \u2013 MAQ subsidiary enters put/call option to acquire Sydney land for new data centre campus (targeting &gt;150MW IT load).  </li>\n<li><strong>Purchase Price</strong> \u2013 $240M (to be funded via cash reserves and corporate debt facility).  </li>\n<li><strong>Timetable</strong> \u2013 Subdivision approval required (expected to take months); exercise window post-approval.  </li>\n<li><strong>Strategic Impact</strong> \u2013 Expands pipeline for hyperscale/AI/govt workloads; aligns with long-term capacity strategy (7\u201310 years).  </li>\n<li><strong>Funding Note</strong> \u2013 Future stages may involve project finance or infrastructure investors.  </li>\n<li><strong>IC3 SuperWest Update</strong> \u2013 Phase 1 on track (Sept 2026 completion); Phases 2\u20134 to follow demand.  </li>\n</ul>\n<p><em>No material financial/operational KPIs or immediate trading impacts disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 987,
      "completion_tokens": 188,
      "total_tokens": 1175,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:13.885422"
  },
  {
    "ticker": "KRR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968841",
    "id": "02968841",
    "pages": 24,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnv23p1mjdq.pdf",
    "summary": "<p>Here\u2019s a concise summary of the material information from the ASX announcement by <strong>King River Resources Ltd (ASX: KRR)</strong>:</p>\n<h3><strong>Exploration Update Highlights</strong></h3>\n<ul>\n<li><strong>Kurundi RC Drilling (April 2025):</strong>  </li>\n<li>New mineralized structure intersected <strong>300m NE of Kurundi Main</strong>, with highlight:  <ul>\n<li><strong>4m @ 1.43g/t Au (inc. 2m @ 2.79g/t Au)</strong> in hole TTRC188.  </li>\n</ul>\n</li>\n<li><strong>Kurundi Main Zone</strong>: Confirmed extensions but no significant high grades in deeper drilling.  </li>\n<li>\n<p>Structural complexity noted in southern high-grade zone, suggesting displaced mineralization.  </p>\n</li>\n<li>\n<p><strong>Kuiper IOCG Targets (Soil Sampling):</strong>  </p>\n</li>\n<li>Promising geochemical anomalies (Au, Cu, Bi, As) over coincident gravity/magnetic targets.  </li>\n<li><strong>Bismuth anomaly</strong> at Kuiper West aligns with gravity target, supporting IOCG potential.  </li>\n<li>\n<p><strong>Drilling planned to commence July 2025</strong>.  </p>\n</li>\n<li>\n<p><strong>Upcoming Exploration</strong>:  </p>\n</li>\n<li>Next phase of drilling at <strong>Kuiper</strong> and further target generation across Tennant Creek tenements.  </li>\n<li>Ionic leach soil sampling to refine priority targets (e.g., Rover East, Pioneer, Barkly).  </li>\n</ul>\n<h3><strong>Key Implications</strong></h3>\n<ul>\n<li><strong>Trading Catalyst</strong>: Positive drill results (new structure at Kurundi) and imminent drilling at Kuiper may impact sentiment.  </li>\n<li><strong>Exploration Upside</strong>: Kuiper\u2019s IOCG potential and Kurundi\u2019s structural extensions warrant monitoring for future resource growth.  </li>\n</ul>\n<h3><strong>Excluded</strong>:</h3>\n<ul>\n<li>Routine operational details, JORC compliance tables, and non-material assay data.  </li>\n</ul>\n<p><strong>Summary</strong>: Focus on Kurundi\u2019s new gold intercept and Kuiper\u2019s IOCG pathfinders, with drilling pending. No capital or liquidity impacts noted.</p>",
    "usage": {
      "prompt_tokens": 20358,
      "completion_tokens": 404,
      "total_tokens": 20762,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:35:41.399481"
  },
  {
    "ticker": "EGL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968835",
    "id": "02968835",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnfh8y5zyqq.pdf",
    "summary": "<p>No material information identified.  </p>\n<p><em>(Note: Executive appointments, unless accompanied by significant strategic shifts, remuneration details, or immediate financial implications, are generally not considered material for trading or capital markets decisions.)</em></p>",
    "usage": {
      "prompt_tokens": 1312,
      "completion_tokens": 41,
      "total_tokens": 1353,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:27.396135"
  },
  {
    "ticker": "NCC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968838",
    "id": "02968838",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnmpzzt316g.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back of convertible bonds (NCCGA)  </li>\n<li><strong>Maximum Buy-back</strong>: 23,000 securities (10% of total 230,000 outstanding)  </li>\n<li><strong>Broker</strong>: Taylor Collison Limited  </li>\n<li><strong>Currency</strong>: AUD  </li>\n<li><strong>Timing</strong>: 16/7/2025 to 15/7/2026  </li>\n<li><strong>Approval</strong>: No security holder approval required</li>\n</ul>",
    "usage": {
      "prompt_tokens": 971,
      "completion_tokens": 90,
      "total_tokens": 1061,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:53.309381"
  },
  {
    "ticker": "LOT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968837",
    "id": "02968837",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnkn9dcg2b7.pdf",
    "summary": "<p><strong>Key Material Information:</strong>  </p>\n<ul>\n<li><strong>Project Update:</strong>  </li>\n<li>Kayelekera uranium mill refurbishment completed, SAG mill restarted.  </li>\n<li>Hot commissioning underway for crushing, grinding, and leach circuits.  </li>\n<li>\n<p>First uranium oxide (U3O8) production expected this quarter.  </p>\n</li>\n<li>\n<p><strong>Financial Position:</strong>  </p>\n</li>\n<li><strong>Unaudited cash balance (30 June 2025): A$77.3M</strong> (primarily AUD &amp; USD-denominated).  </li>\n<li>No debt drawn; conditional working capital facilities remain undrawn.  </li>\n</ul>\n<p><em>Note: Operational progress supports near-term production target, but no new capital markets activity (e.g., raising, guidance change) disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 2415,
      "completion_tokens": 146,
      "total_tokens": 2561,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:10.397515"
  },
  {
    "ticker": "ASN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968839",
    "id": "02968839",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnptv0dyll0.pdf",
    "summary": "<p><strong>Material Information Summary (Anson Resources Ltd - ASX:ASN):</strong><br />\n- <strong>Key Development</strong>: Bulk shipment (2+ tons) of lithium-rich brine sent to POSCO for test work as part of due diligence for a <strong>planned demonstration plant</strong> at Green River Lithium Project (Utah, USA).<br />\n- <strong>Outcome Timeline</strong>: Test results expected to inform engineering design and cost estimates by <strong>December 2025</strong> (per non-binding MoU).<br />\n- <strong>Technology Highlight</strong>: Brine pre-treated using <strong>chemical-free process</strong> to remove iron (Fe), previously validated in pilot tests.  </p>\n<p><em>No capital raising, financials, or immediate trading catalysts identified.</em></p>",
    "usage": {
      "prompt_tokens": 4605,
      "completion_tokens": 139,
      "total_tokens": 4744,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:34:00.798850"
  },
  {
    "ticker": "MI6",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968834",
    "id": "02968834",
    "pages": 23,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrncf3m89ff6.pdf",
    "summary": "<h3>Project Update Summary (Bullabulling Gold Project)</h3>\n<h4><strong>Key Highlights (Material for Investors):</strong></h4>\n<ul>\n<li><strong>Pre-Feasibility Study (PFS) underway</strong>, targeting <strong>first production in CY2028</strong>.  </li>\n<li><strong>Mineral Resource Estimate update on track for Q4 CY2025</strong> (current resource: <strong>60Mt @ 1.2g/t Au for 2.3Moz</strong>).  </li>\n<li><strong>80,000m drill program ongoing</strong>, focusing on extensional and infill drilling.  </li>\n<li><strong>Metallurgical test work confirms free-milling gold</strong>, with recoveries of <strong>89\u201393% at 75-micron grind size</strong>. Further optimization planned.  </li>\n<li><strong>Approvals pathway simplified</strong>: No material environmental impediments identified; granted Mining Leases in place.  </li>\n<li><strong>Fully funded</strong> for planned activities through to <strong>Final Investment Decision (FID) in 2027</strong>.  </li>\n</ul>\n<h4><strong>Next Milestones:</strong></h4>\n<ul>\n<li><strong>PFS completion</strong>: Mid-CY2026  </li>\n<li><strong>Definitive Feasibility Study (DFS)</strong>: Q1 CY2027  </li>\n</ul>\n<p><em>No capital raising, financial figures, or trading-sensitive timetables disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 15304,
      "completion_tokens": 245,
      "total_tokens": 15549,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:36:09.834146"
  },
  {
    "ticker": "BC8",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968836",
    "id": "02968836",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrnhk05vh77p.pdf",
    "summary": "<p><strong>Material Information Summary (Black Cat Syndicate ASX Announcement \u2013 14 July 2025):</strong>  </p>\n<ol>\n<li><strong>Belvedere Deposit Acceleration:</strong>  </li>\n<li>High-grade gold deposit (Resource: <strong>30koz @ 6.6g/t Au</strong>) to be fast-tracked into production.  </li>\n<li>Initial target: <strong>122kt @ 5.1g/t for 20koz</strong>, integrated into Paulsens\u2019 Restart Study.  </li>\n<li>\n<p>Mining approvals submitted, expected in <strong>~6 months</strong>.  </p>\n</li>\n<li>\n<p><strong>Operational Impact:</strong>  </p>\n</li>\n<li>Accelerated mining to utilize spare capacity at Paulsens\u2019 processing plant (operating at <strong>80% capacity</strong>).  </li>\n<li>\n<p>Underground drilling post-commencement aims to expand Resources/Reserves.  </p>\n</li>\n<li>\n<p><strong>Exploration Timetable (Near-Term Catalysts):</strong>  </p>\n</li>\n<li><strong>Jul\u2013Sep 2025</strong>: Surface drilling at Kal East (Fingals).  </li>\n<li><strong>Aug\u2013Oct 2025</strong>: Drilling at Paulsens West Seismic target (EIS co-funded).  </li>\n<li>\n<p><strong>Aug\u2013Sep 2025</strong>: Antimony drilling at Mt Clement (EIS co-funded).  </p>\n</li>\n<li>\n<p><strong>Resource/Reserve Context (Key Metrics):</strong>  </p>\n</li>\n<li><strong>Paulsens Resource</strong>: 4.3Mt @ 4.0g/t Au for <strong>548koz</strong> (incl. Belvedere).  </li>\n<li><strong>Kal East Resource</strong>: 18.8Mt @ 2.1g/t Au for <strong>1,294koz</strong>.  </li>\n<li><strong>Group Reserve</strong>: 330koz Au (Paulsens: 87koz @ 4.3g/t; Kal East: 243koz @ 2.0g/t).  </li>\n</ol>\n<p><strong>Excluded</strong>: Director commentary, general corporate details, and non-material operational timelines.</p>",
    "usage": {
      "prompt_tokens": 5443,
      "completion_tokens": 379,
      "total_tokens": 5822,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:33:00.002835"
  },
  {
    "ticker": "IFT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968812",
    "id": "02968812",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0750",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlpl4zvvyw0.pdf",
    "summary": "<ul>\n<li><strong>Director Trading Disclosure</strong>: Jason Boyes (Director &amp; CEO of Infratil Limited) acquired <strong>45,393 IFT ordinary shares</strong> on-market between <strong>7-Jul-25 and 11-Jul-25</strong> at prices ranging from <strong>NZ$10.92251 to NZ$10.9584 per share</strong>.  </li>\n<li><strong>Total consideration</strong>: <strong>~NZ$497,329.75</strong>.  </li>\n<li><strong>Post-transaction holdings</strong>: <strong>2,427,830 shares</strong> (beneficially owned).  </li>\n</ul>\n<p><em>No material impact on capital structure or liquidity identified.</em></p>",
    "usage": {
      "prompt_tokens": 947,
      "completion_tokens": 118,
      "total_tokens": 1065,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:09:46.891849"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968811",
    "id": "02968811",
    "pages": 10,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlhgrd1s0s7.pdf",
    "summary": "<h3><strong>Capital Raising Announcement</strong></h3>\n<ul>\n<li><strong>Structure</strong>: Placement + Share Purchase Plan (SPP)  </li>\n<li><strong>Placement</strong>: AUD $16.1 million raised (oversubscribed) at $0.10/share (18% premium to 20-day VWAP).  </li>\n<li><strong>SPP</strong>: AUD $5 million targeted (potential oversubscription); retail shareholders eligible.  </li>\n<li><strong>Key Dates</strong>:  </li>\n<li><strong>Annual Meeting</strong>: 6 August 2025 (shareholder approval for placement required).  </li>\n<li><strong>SPP Opening</strong>: Mid-July 2025 (conditional on placement approval).  </li>\n</ul>\n<h3><strong>Operational Highlights (Q1 FY26)</strong></h3>\n<ul>\n<li><strong>US Test Volumes</strong>:  </li>\n<li>Total Laboratory Throughput (TLT): <strong>6,900 tests</strong> (down 8.9% QoQ).  </li>\n<li>US TLT: <strong>5,717 tests</strong> (down 11.9% QoQ) due to transition from <em>Detect</em> to <em>Triage</em>.  </li>\n<li><em>Triage</em> adoption: <strong>77% of US tests</strong> in June 2025 (vs. 22% in Q4 FY25).  </li>\n<li><strong>Asia Pacific Growth</strong>: <strong>1,183 tests</strong> (up 8.8% QoQ).  </li>\n<li><strong>Medicare Reconsideration</strong>: Positive discussions with Novitas; reconsideration request submitted for <em>Triage</em> (based on AUA Guideline inclusion and STRATA study).  </li>\n</ul>\n<h3><strong>Material Developments</strong></h3>\n<ol>\n<li><strong>Triage Plus Progress</strong>:  </li>\n<li>Analytical Validation published (Diagnostics, July 2025); supports Medicare reconsideration.  </li>\n<li>Draft Medicare price: <strong>US$1,018/test</strong> (vs. $760 for <em>Triage</em>). Pending DRIVE study peer review (submitted June 2025).  </li>\n<li><strong>AUA Guideline Impact</strong>:  </li>\n<li><em>Triage</em> holds \"Grade A\" evidence rating; drives payer negotiations (e.g., Optum VACCN coverage at Medicare rate).  </li>\n<li><strong>Cash Runway</strong>: Capital raise extends runway <strong>&gt;12 months</strong> without Medicare coverage.  </li>\n</ol>\n<hr />\n<p><strong>Omitted</strong>: Routine details on director re-elections, clinical study timelines (non-near-term), and regional breakdowns.<br />\n<strong>Key Focus</strong>: Capital structure, volume trends, Medicare strategy, and <em>Triage Plus</em> commercialization.</p>",
    "usage": {
      "prompt_tokens": 7214,
      "completion_tokens": 495,
      "total_tokens": 7709,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:10:10.943634"
  },
  {
    "ticker": "SNZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968810",
    "id": "02968810",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlf7nq5f4mq.pdf",
    "summary": "<ul>\n<li><strong>Announcement Type:</strong> Employee incentive scheme securities issuance  </li>\n<li><strong>Securities Issued:</strong> 192,360 ordinary fully paid shares (ASX: SNZ)  </li>\n<li><strong>Issue Price:</strong> NZD 11.8757 per share  </li>\n<li><strong>Issue Date:</strong> 14/07/2025  </li>\n<li><strong>Ranking:</strong> Equally with existing shares  </li>\n<li><strong>Post-Issue Issued Capital:</strong> 241,123,378 ordinary shares on issue  </li>\n<li><strong>Key Management Personnel (KMP) Allocations:</strong>  </li>\n<li>Scott Scoullar: 84 shares  </li>\n<li>Margaret Warrington: 84 shares  </li>\n</ul>\n<p><em>No material impact on capital structure or liquidity expected (minor issuance under incentive scheme).</em></p>",
    "usage": {
      "prompt_tokens": 1489,
      "completion_tokens": 150,
      "total_tokens": 1639,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T22:09:52.172406"
  }
]